Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology

Why Is HNPP Misdiagnosed as Multiple Sclerosis (MS)?

At a Glance

HNPP can resemble MS because both may cause episodes of numbness, tingling, and weakness, but HNPP affects pressure-sensitive peripheral nerves while MS affects the brain, spinal cord, and optic nerves. Nerve studies and PMP22 testing help distinguish HNPP from MS.

It can be deeply confusing and frustrating to be diagnosed with Multiple Sclerosis (MS), only to be told later that your symptoms are caused by Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). Receiving a genetic diagnosis of HNPP changes which causes and treatments need to be considered by your medical team.

The core difference between the two conditions comes down to location: MS is a disease of the central nervous system (the brain, spinal cord, and optic nerves), while HNPP affects the peripheral nervous system (the nerves that run through your arms, legs, and the rest of your body) [1][2]. While it is rare, it is also possible for a person to have both conditions at the same time [3].

While both conditions involve damage to myelin—the protective covering around your nerves—they are biologically different processes occurring in entirely different bodily systems.

Why the Confusion Happens

HNPP can sometimes be mistaken for MS early in a patient’s journey because the two conditions share overlapping features:

  • Relapsing Symptoms: Both conditions can cause episodes of numbness, tingling, and muscle weakness that come and go over time [4][5].
  • “Demyelination”: Both are categorized as demyelinating diseases. Because MS is the most well-known demyelinating disease, seeing clinical signs of myelin damage can sometimes prompt clinicians to suspect MS first.
  • Coincidental or Misleading Test Results: In rare cases, people with HNPP may happen to have non-specific white spots on brain MRIs, mildly elevated protein in their spinal fluid, or delayed visual nerve tests (visual evoked potentials) [6][7][2]. These are not characteristic or defining findings of HNPP. However, if a doctor sees these nonspecific results alongside episodes of physical weakness, they might incorrectly suspect MS.

How the Symptoms Differ

While the symptoms can feel similar, examining how and where they happen helps clinicians tell the conditions apart. However, symptoms alone cannot completely distinguish the diseases.

  • HNPP Patterns: HNPP symptoms are typically triggered by physical pressure, resting in an awkward position, wearing tight equipment, or minor trauma [4]. They affect individual peripheral nerves, often causing localized issues like a “foot drop” (weakness lifting the foot) or a numb hand [8]. It is important to note that HNPP can also cause fatigue related to muscle weakness, and balance issues caused by numb feet—which can sometimes be misinterpreted as MS symptoms.
  • MS Patterns: MS attacks originate in the brain or spinal cord and are not triggered by external physical pressure on a limb. Symptoms that are more typical of MS (and not standard for HNPP) include severe vision loss (optic neuritis), profound central balance and coordination issues, or new bladder and bowel dysfunction [9].

How Doctors Tell Them Apart

Because HNPP and MS affect different parts of the nervous system, doctors use different tools to build a diagnosis. Neither condition is definitively proven by a single MRI or spinal tap; instead, doctors look at the full clinical picture.

Evaluating for Multiple Sclerosis (MS):

  • Brain and Spine MRIs: Doctors look for specific patterns of damage (lesions) in the central nervous system that show disease activity spread out in different places and at different times (dissemination in space and time) [9].
  • Spinal Tap (Lumbar Puncture): This tests the cerebrospinal fluid for specific antibodies called oligoclonal bands. If these bands are absent, or if the MRI lesions are atypical, it lowers the suspicion of MS, though it does not rule it out entirely [10].

Evaluating for HNPP:

  • EMG and Nerve Conduction Studies: These tests measure electrical signals in your peripheral nerves. In HNPP, they typically show specific patterns of signal slowing at common pressure points (like the elbow or wrist), even in nerves where you haven’t noticed symptoms yet [11][12].
  • Genetic Blood Test: HNPP is confirmed by testing the PMP22 gene. Most commonly, this requires a specific “copy-number” analysis to look for a missing piece (a deletion) of the gene, as standard genetic sequencing might miss it [12][13]. A pathogenic genetic result confirms HNPP, whereas a negative test or a “variant of uncertain significance” does not.

Safety and Next Steps

If you have recently been diagnosed with HNPP after an MS diagnosis, do not abruptly stop your MS disease-modifying therapies or cancel your specialist appointments. Work with a neurologist to carefully review your original MRIs, spinal tap, and genetic report to ensure your new diagnosis fully explains your symptoms.

  • Protect Your Nerves: You can help prevent HNPP flare-ups by avoiding prolonged pressure on your nerves. Avoid leaning heavily on your elbows, crossing your legs for long periods, or wearing tight braces. Always inform surgeons and anesthesiologists about your HNPP so they can properly pad your pressure points during medical procedures.
  • Family Planning: HNPP is usually an autosomal dominant condition, meaning an affected person has a 50% chance of passing the gene variant to each child. Genetic counseling can help you and your family understand who else might benefit from testing.
  • When to Seek Urgent Care: Having HNPP does not protect you from other medical emergencies. You should seek immediate emergency care for sudden one-sided weakness, new severe vision loss, difficulty speaking or swallowing, or sudden loss of bowel and bladder control, as these are not typical pressure palsies and require urgent evaluation.

Common questions in this guide

What is the main difference between HNPP and multiple sclerosis?
HNPP is an inherited disorder affecting peripheral nerves in the arms, legs, and body, often causing pressure-triggered numbness or weakness. Multiple sclerosis affects the central nervous system—the brain, spinal cord, and optic nerves—so the pattern and location of symptoms are different.
Why can HNPP be mistaken for MS?
Both conditions can cause episodes of numbness, tingling, and weakness, and both involve damage to myelin. Nonspecific brain MRI spots, mildly high spinal-fluid protein, or delayed visual nerve tests can occasionally occur in people with HNPP, but these findings do not define HNPP or prove MS.
What tests help doctors tell HNPP and MS apart?
Doctors evaluate possible MS with brain and spinal-cord MRI and a spinal tap that checks for immune protein bands called oligoclonal bands. HNPP is evaluated with EMG and nerve-conduction studies plus a PMP22 genetic test. A copy-number test is important because standard sequencing can miss a deletion, and no single test provides the whole answer.
If I have a confirmed HNPP diagnosis, could I also have MS?
Yes, although having both conditions is rare. A disease-causing PMP22 result confirms HNPP but does not by itself rule out MS; a neurologist may need to review previous MRI scans, spinal-fluid results, and the pattern of symptoms. Do not change MS treatment until that review is complete.
Should I stop my MS medication after learning I have HNPP?
Do not abruptly stop disease-modifying therapy or cancel specialist appointments on your own. Ask a neurologist to review the original diagnosis, MRI scans, spinal-tap results, and genetic report before changing treatment.
How can I prevent HNPP episodes?
Avoid prolonged pressure on nerves, such as leaning on elbows, crossing your legs for a long time, or wearing tight braces or equipment. Tell surgeons and anesthesiologists about HNPP so pressure points can be padded during procedures. These steps reduce risk but do not replace individualized medical advice.
Which symptoms require emergency care if I have HNPP?
Seek emergency care for sudden one-sided weakness, new severe vision loss, trouble speaking or swallowing, or sudden loss of bowel or bladder control. These symptoms are not typical pressure palsies and may signal another urgent neurologic problem.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since I have a confirmed HNPP diagnosis, can we review my old MRIs and spinal tap results together to see if they are fully explained by HNPP, or if there is any reason to suspect I have both conditions?
  2. 2.Was my genetic test a copy-number analysis that checks for a PMP22 deletion, or a sequencing test, and what does the specific result mean for my family members?
  3. 3.Should I safely taper or stop my MS disease-modifying therapies, or do we need to do more testing before making that decision?
  4. 4.What specific physical habits, resting positions, or repetitive motions should I try to avoid to prevent further peripheral nerve damage?
  5. 5.How should I communicate my HNPP diagnosis to anesthesiologists or surgeons to ensure my nerves are protected during future medical procedures?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases.

    Krauter D, Stausberg D, Hartmann TJ, et al.

    EMBO molecular medicine 2024; (16(3)):616-640.

    PMID: 38383802
  2. 2

    Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.

    Brandt AU, Meinert-Bohn E, Rinnenthal JL, et al.

    PloS one 2016; (11(10)):e0164617 doi:10.1371/journal.pone.0164617.

    PMID: 27749933
  3. 3

    Co-occurrence of Charcot-Marie-Tooth disease type 2A and multiple sclerosis: A case report.

    Habib S, Anadani NA, Samkutty D

    SAGE open medical case reports 2025; (13()):2050313X251357782 doi:10.1177/2050313X251357782.

    PMID: 40688573
  4. 4

    Literature review of clinical analysis of hereditary neuropathy with liability to pressure palsies.

    Chen L, Zhang H, Li C, et al.

    Journal of neurology 2024; (272(1)):41 doi:10.1007/s00415-024-12839-7.

    PMID: 39666198
  5. 5

    Hereditary neuropathy with liability to pressure palsies.

    Attarian S, Fatehi F, Rajabally YA, Pareyson D

    Journal of neurology 2020; (267(8)):2198-2206 doi:10.1007/s00415-019-09319-8.

    PMID: 30989370
  6. 6

    DTI Study of Cerebral Normal-Appearing White Matter in Hereditary Neuropathy With Liability to Pressure Palsies (HNPP).

    Wang WW, Song CL, Huang L, et al.

    Medicine 2015; (94(43)):e1909 doi:10.1097/MD.0000000000001909.

    PMID: 26512614
  7. 7

    Hereditary Neuropathy with Liability to Pressure Palsies Masked by Previous Gunshots and Tuberculosis.

    Gencik M, Finsterer J

    Case reports in genetics 2015; (2015()):738469 doi:10.1155/2015/738469.

    PMID: 26640726
  8. 8

    Electrodiagnostic Characterization of Hereditary Neuropathy With Liability to Pressure Palsies.

    Takahashi S, Chum M, Kimpinski K

    Journal of clinical neuromuscular disease 2017; (18(3)):119-124 doi:10.1097/CND.0000000000000152.

    PMID: 28221301
  9. 9

    Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

    Thompson AJ, Banwell BL, Barkhof F, et al.

    The Lancet. Neurology 2018; (17(2)):162-173 doi:10.1016/S1474-4422(17)30470-2.

    PMID: 29275977
  10. 10

    "Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

    Calabrese M, Gasperini C, Tortorella C, et al.

    Neurology 2019; (92(22)):e2527-e2537 doi:10.1212/WNL.0000000000007573.

    PMID: 31043476
  11. 11

    Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: Neurophysiological data and proposed electrodiagnostic criteria.

    Robert-Varvat F, Jousserand G, Bouhour F, et al.

    Muscle & nerve 2018; (57(2)):217-221 doi:10.1002/mus.25666.

    PMID: 28407266
  12. 12

    Clinical and molecular genetic characteristics of 24 families of hereditary neuropathy with liability to pressure palsy and literature review.

    Cao W, Huang S, Zhao H, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2023; (48(10)):1572-1582 doi:10.11817/j.issn.1672-7347.2023.230116.

    PMID: 38432886
  13. 13

    Yield of the PMP22 deletion analysis in patients with compression neuropathies.

    Ivanovic V, Brankovic M, Bjelica B, et al.

    Journal of neurology 2020; (267(12)):3617-3623 doi:10.1007/s00415-020-10052-w.

    PMID: 32642785

This page is for informational purposes only and does not constitute medical advice. Do not stop MS treatment or change your care plan without discussing your results with a neurologist.

Get notified when new evidence is published on Hereditary neuropathy with liability to pressure palsies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.